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1. Introduction and aims 
 
Steroids occur nearly everywhere in almost all living organisms and they play important roles 
from biological aspects. The preparation of semisynthetic and synthetic steroids and their 
biological evaluation have become a major field in pharmaceutical research. The therapeutic 
application of compounds with sterane skeleton for hormone-dependent diseases is getting 
increasingly widespread. Nowadays the synthesis of steroid hybrids seems to get outstanding 
significance. The reason is that this synthetic strategy is an inexhaustible tool to prepare novel 
drug candidates. A suitable carrier molecule and a naturally occurring or synthetic compound 
can be combined via a suitable linker and the novel hybrid compound with a unique structure 
thus prepared could exert new biological properties as well. Among cytostatic hybrid type 
compounds published previously many bear sterane skeleton. The receptor binding of the 
molecule could be influenced by the chemical nature of the linker. The synthetic method 
applied for the preparation of hybrid derivatives determines the position and the 
stereochemistry of the coupling molecular entities on the sterane core. 
 Relying on the results of previous studies, the purpose of my doctoral work was to 
synthesize a series of compounds with diverse structures for comprehensive pharmacological 
investigations. During the design of the desired types of compounds we have been bearing 
several viewpoints in mind. A comparative pharmacological investigation has not been 
obtained yet on stereoisomeric hybrid compounds. For this purpose, we planned to prepare 
and investigate substituted androstane derivatives bearing triazolyl group in both the 17 and 
17 position. Our further goal was to synthesize all four possible isomers each of the  
3-methoxy- and 3-benzyloxy-16-hydroxymethyl-17-hydroxyestra-1,3,5(10)-triene and to 
prepare 16-triazolylmethyl hybrids. The antiproliferative activity was expected to depend on 
the stereochemistry of the isomers. The results of the biological investigation could also be 
influenced by the presence of the 3-methoxy or the 3-benzyloxy substituents on the sterane 
framework. To expand our research on hybrid molecules bearing methylene linker, we aimed 
to build in a longer carbon linker. After the promising results achieved in the natural estrane 
series we attempted to take further examinations with the four possible isomers each of the  
3-methoxy- and 3-benzyloxy-16-hydroxymethyl-17-hydroxy-13-estra-1,3,5(10)-triene. Note 
that it is well-known in the literature that 13-estrane derivatives may not possess estrogenic 
activity. 
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2. Experimental methods 
 
For the preparation of the starting materials reactions were carried out in the molar range, 
whereas the synthesis of the derivatives was accomplished in the millimolar range. 
Conversions were monitored by thin-layer chromatography. Purification and isolation of the 
crude products were implemented by flash chromatography. The structures of all newly 
synthesized compounds were confirmed by 
1
H NMR, 
13
C NMR and in some cases 2D NMR 
experiments (HSQC, HMBC) were also performed for structure determination. 
 
3. Scientific results* 
 
3.1.  Both the 3-hydroxy-17- and 3-hydroxy-17-azidoandrost-5-ene epimers (61b and 
63b) could be synthesized from 3-acetoxy-17-hydroxyandrost-5-ene 59 (Scheme 1). First, 
the esterification of 3-acetoxy-17-hydroxyandrost-5-ene 59 with p-toluenesulfonyl chloride 
furnished 3-acetoxy-17-tosyloxyandrost-5-ene (60). Then a TsN3 exchange taking place 
via Walden inversion gave the 3-acetoxy-17-azidoandrost-5-ene (61a). Compound 59 
under the conditions of the Appel reaction led to the 3-acetoxy-17-iodoandrost-5-ene (62), 
and then an IN3 exchange with inversion afforded the 3-acetoxy-17-azidoandrost-5-ene 
(63a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1 
 
 
 
* The numbering of the compounds is in accordance with that in the Ph.D Thesis 
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3.2.  The Cu(I)-catalysed 1,3-dipolar cycloaddition performed with cycloalkyl- (65df, 66 
df), aryl- (65ac, g and 65ac, g) and aryloxymethyl-alkynes (65hm, 66hm) on the 17- 
and 17-azide groups led to the corresponding triazolyl derivatives (65an, 66an) with the 
heterocycle directly connected to the androstane skeleton (Scheme 2). 
 
3.3.  Alkaline hydrolysis of the 4’-benzoyloxymethyl triazoles (65ik and 66ik) yielded 
the 4’-hydroxymethyltriazolyl derivatives (65l, 66l) without the decomposition of the triazolyl 
ring (Scheme 2). 
 
3.4.  We found that during the click reactions [Cu(I)-catalysed alkyne–azide cycloaddition; 
CuAAC] with the use of 10 equivalents of CuI in the presence of triethylamine (TEA) and 1.5 
equivalents of ICl, the 5’-iodotriazolyl derivatives (65mn and 66mn) were formed with 
good yields (Scheme 2). 
 
Scheme 2 
 
3.5.  Acetolysis of the 5’-iodotriazolyl compounds (65n, 66n) in acetic anhydride in the 
presence of KOAc followed by alkaline hydrolysis yielded 5’-hydroxytriazolyl derivatives 
(65o, 66o) (Scheme 2). 
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3.6.  We developed a novel synthetic pathway for the synthesis of 3-methoxy- and  
3-benzyloxy-16-hydroxymethyl-17-hydroxyestra-1,3,5(10)-trienes. The selective acetylation 
of the primary hydroxyl function of the 3-methoxy- and 3-benzyloxy-16-hydroxymethyl-
17-hydroxyestra-1,3,5(10)-triene compounds (71, 75) furnished the 16-acetoxymethyl 
derivatives (78, 81). Jones oxidation of these compounds (78, 81) led to the transformation of 
the 17-hydroxy group to 17-keto function (79, 82). Reduction of the 17-keto group with 
lithium tri-tert-butoxyaluminum hydride generated in situ in diethyl ether solution yielded the  
16-acetoxymethyl-17-hydroxy and the 17-acetoxymethyl-17-hydroxy compounds in 
ratio of 4:1. The products then were deacetylated by the Zemplén method to yield the yet 
missing 16-hydroxymethyl-17-hydroxyestra-1,3,5(10)-triene isomers (73, 77) in both the  
3-methoxy and 3-benzyloxy series (Scheme 3). According to our laboratory experiences, this 
method could be used efficiently only in smaller batches. 
 
 
Scheme 3 
 
3.7.  We found that the 16-acetoxymethyl-17-keto compounds (79, 82) under the 
conditions of the Luche reduction, that is, reduction with NaBH4 in the presence of CeCl3 
furnished the corresponding pseudo-axial 17-hydroxy derivatives. The resulting 3-methoxy- 
and 3-benzyloxy-16-hydroxymethyl-17-hydroxyestra-1,3,5(10)-triene compounds (73, 77) 
were isolated in good yields (Scheme 3). 
 
3.8.  The stereoisomers of the 3-methoxy- and 3-benzyloxy-16-hydroxymethyl-17-
hydroxyestra-1,3,5(10)-triene (7077) were transformed in the Appel reaction to give the 
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corresponding 16-bromomethyl derivatives (8491) (Scheme 4). The subsequent nucleophilic 
substitution, a BrN3 exchange, provided the 16-azidomethyl stereoisomers (9295 and 
9699), which were used as starting materials for the CuAAC reaction. 
 
 
Scheme 4 
 
3.9.  The azide-alkyne cycloaddition of the four possible stereoisomers each of the  
3-methyl- and 3-benzyloxy-16-azidomethyl-17-hydroxyestra-1,3,5(10)-triene (9295 and 
9699) gave the corresponding triazolyl derivatives (100107) with the heterocycle attached 
to the sterane framework through a methylene linker. 
 
3.10.  We found that the coupling constants of the 17-H peak in the 
1
H NMR spectra of the 
synthesized 3-methyl- and 3-benzyloxy-16-azidomethyl-17-hydroxyestra-1,3,5(10)-triene 
(9295 and 9699) stereoisomers and their triazolyl derivatives (100107) showed the 
following tendency: 
 
                              J16,17 ˃       J16,17˃       J16,17˃      J16,17
                          ~ 9.5 Hz                ~ 7.0 Hz                ~ 5.0 H               ~ 01 Hz  
                        (92, 96, 100, 104)     (93, 97, 101, 105)     (95, 99, 103, 107)    (94, 98, 102, 106) 
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3.11.  The solvolytic reaction of 3-methoxy- and 3-benzyloxy-16-tosyloxymethyl-17-
hydroxyestra-1,3,5(10)-trienes (108, 112) led to derivatives with an oxetane ring condensed to 
the ring D (109, 113) through neighbouring group participation (Scheme 5). These cyclic 
ethers (109, 113) are suitable synthon equivalents for the preparation of derivatives with 
longer linkers. Their synthesis has been facilitated by the transformation of the cyclic ethers in 
the presence of Lewis acids like BF3·OEt2 to form oxonium complexes (109a, 113a). The 
latter are known to undergo ring cleavage in a solvolytic reaction with ,ω-diols. In our case, 
ring cleavage was carried out with ethylene glycol to synthesize 110 and 114 with a three-
carbon alkoxy linker in the 16 position. If the transformation is carried out with Brønsted 
acid, the ring cleavage of the oxonium complexes (109a, 113a) occurs with Wagner–
Meerwein rearrangement yielding the 16-[(2’-oxa)--hydroxyalkyl]-17-methylestra-
1,3,5(10),13(14)-tetraen-3-ethers (111, 115). 
 
 
Scheme 5 
 
3.12.  Compounds with the ω-hydroxyalkyl linker (110, 114) transformed in the Appel 
reaction led to the corresponding iodoalkyl derivatives (116, 120), which were suitable 
alkylating agents in the selective alkylation of L-ascorbic acid (2-deoxy-2-keto gulonic acid  
-lactone) and salicylic acid (Scheme 6; 117123). 
 
3.13.  Nucleophilic substitution of the ω-iodoalkyl compounds (116, 120) with NaN3 
furnished the ω-azidoalkyl derivatives (124, 125) (Scheme 6). The terminal azide functions 
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were capable of reacting under CuAAC conditions to provide terminal, disubstituted 1,2,3-
triazoles (126ac and 127ac). 
 
 
 
 
 
 
 
 
 
Scheme 6 
 
3.14.  The reduction of the terminal azide function of  
124 and 125 with hydrazine hydrate in the presence of 
Raney-Ni catalyst in ethanol gave the corresponding ω-
aminoalkyl derivatives (128, 129). Then several hybrid 
carboxamides were synthesized. Acylations were 
performed with the use of aromatic carboxylic acids and 
well-known peptide coupling agents (Scheme 6; 130ad 
and 131ad). 
 
 
3.15.  Jones oxidation of the separated trans 16-acetoxymethyl-17-hydroxy derivatives (31f, 
32f and 138b, 139b), the subsequent Luche or NaBH4 reduction of the corresponding 
compounds and deacetylation by the Zemlén method gave cis-diols 134b, 135b and 142b, 
143b. By these reaction steps the synthesis of the full isomer series of the 3-methoxy- and the 
3-benzyloxy-16-hydroxymethyl-17-hydroxy-13-estra-1,3,5(10)-triene was completed 
(Scheme 7). 
 
3.16.  According to our earlier investigations on the natural estrane series, we set out the 
selective esterification of the primary hydroxy function of the 16,17- (135b, 143b) and 
16,17-diols (134b, 142b) with 13-epi-estrane skeleton. The alkaline reaction of the  
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1,3-tosylhydrins (144147) leads to the formation of oxetanes (148151) condensed to ring D 
in the 13-estrane series as well. The process can be regarded as a neighbouring group 
participation, which is characterized as (O

-4) by the general symbol (Scheme 8). 
 
Scheme 7 
 
Scheme 8 
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3.17.  All four possible isomers each of the 3-methoxy- and 3-benzyloxy-16-acetoxymethyl-
17-acetoxy-13-estra-1,3,5(10)-triene (31g, 32g, 134c, 135c and 138c, 139c, 142c, 143c) 
have been investigated by 2D NMR techniques, such as HSQC and HMBC. The chemical 
shifts and the coupling constants of the carbons in the -, - or -positions are sensitive to 
differences in the configuration of the C-16 and C-17 atoms. A characteristic tendency has 
been observed in the 
1
H NMR spectra of all compounds. The tertiary C-17 atom bears only a 
single proton, which is visible as a singlet in every proton spectrum. Nevertheless, the 
coupling constants are different because of the difference in the dihedral angle in accordance 
with the Karplus equation. In the case of compounds bearing a -acetoxy group on C-17, the 
coupling constant of the C-17 hydrogen is 5.0 Hz. In turn, if the acetoxy group is in  
-position, the coupling constant is 9.0 Hz. This statement is valid for both the 3-methoxy- 
and the 3-benzyloxy-epi-estrane series. Thus the regularities observed between the coupling 
constants of the 17-H are the following: 
 
   J16,17 =       J16,17˂       J16,17=        J16,17
                       ~ 5.0 Hz                ~ 5.0 Hz                   ~ 9.0 H                   ~ 9.0 Hz  
                      (135c, 143c)                  (31g, 138c)                   (32g, 139c)                  (134c, 142c) 
 
 
3.18.  The transfer hydrogenation of 3-methoxy- and 3-benzyloxy-16-hydroxymethylidene-
13-estra-1,3,5(10)-trien-17-ones (30, 137) in the presence of Ru(S,S-Ts-DPEN)(para-
cymene)Cl [(S,S)-Ru] or Ru(R,R-Ts-DPEN)(para-cymene)Cl [(R,R)-Ru] its enantiomer gave 
diastereomeric mixtures of 3-methoxy- and 3-benzyloxy-16-hydroxymethyl-13-estra-
1,3,5(10)-trien-17-ones (152155). The purification of the formed 16-hydroxymethyl-17-keto 
isomers (152155) has been achieved by column chromatography and related data are 
summarized in the table of Scheme 9. 
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Scheme 9 
 
3.19.  The reduction of the 16-hydroxymethly-17-keto isomers (152, 154) by the Luche 
method gave two compounds for each. The expected 16,17stereoisomers (135b, 143b) and 
the 32a, 139a 16,17isomers were obtained in almost equal amounts. Similarly, under the 
same conditions, the reduction of 16-hydroxymethyl-17-ketones (153, 155) yielded the 
16,17isomers (134b, 142b) and the 16,17 (31a, 138a) isomers were also obtained in 
equal amounts (Scheme 10). The two-step transfer hydrogenation/reduction is a procedure of 
unprecedented convenience and efficiency for the preparation of all isomers of the  
16-hydroxymethyl-17-hydroxy compounds compared to the classical synthetic pathway. 
 
Scheme 10 
11 
 
4. Scientific publications forming the basis of the thesis 
 
1. Kiss, A.; Herman, B. E.; Görbe, T.; Mernyák, E.; Molnár, B.; Wölfling, J.; Szécsi, M.; 
Schneider, Gy.  
Synthesis of novel 17-triazolyl-androst-5-en-3-ol epimers via Cu(I)-catalyzed azide-alkyne 
cycloaddition and their inhibitory effect on 17α-hydroxylase/C17,20-lyase 
Steroids 2018, 135, 7991. 
          IF: 2.523 
 
2. Kiss, A.; Mernyák, E.; Wölfling, J.; Sinka, I.; Zupkó, I.; Schneider, Gy.  
Stereoselective synthesis of the four 16-hydroxymethyl-3-methoxy- and 16-hydroxymethyl-3-
benzyloxy-13α-estra-1,3,5(10)-trien-17-ol isomers and their antiproliferative activities 
Steroids 2018, 134, 6777. 
          IF: 2.523 
 
3. Kiss, A.; Mernyák, E.; Wölfling, J.; Szöllősi, Gy.; Schneider, Gy.  
Improved stereoselective synthesis of 3-methoxy- and 3-benzyloxy-16-hydroxymethyl-13-
estra-1,3,5(10)-trien-17-ol isomers by transfer hydrogenation using chiral Ru catalysts 
Reac. Kinet. Mech. Cat. 2018, 125, 4753. 
IF: 1.515 
 
4. Kiss, A.; Wölfling, J.; Mernyák, E.; Frank, É.; Gyovai, A.; Kulmány, Á.; Zupkó, I.; Schneider, 
Gy. 
 Stereoselective synthesis of new type steroid hybrid molecules and their antiproliferative 
activities 
 Steroids 2018, submitted manuscript 
 
5. Kiss, A.; Wölfling, J.; Mernyák, E.; Frank, É.; Benke, Zs.; Senobar Tahaei, S. A.; Mahó, S.; 
Zupkó, I.; Schneider, Gy. 
Stereocontrolled synthesis of the four possible 3-methoxy- and 3-benzyloxy-16-
triazolylmethylestra-17-ol hybrids and their antiproliferative activites 
Steroids 2018, submitted manuscript  
 
             Total IF: 6.561 
 
 
 
 
 
 
 
 
12 
 
5.  Scientific lectures and posters forming the basis of the thesis 
 
Lectures: 
1. Kiss, A.; Wölfling, J.; Schneider, Gy. 
Sztereoizomer hibrid molekulák előállítása az ösztrán sorban 
MTA Szteroid- és Terpenoidkémiai Munkabizottsági ülése, Szeged, Hungary, 27 November 
2017. 
 
2. Kiss, A. 
Hybrids and conjugates at the focus of steroid research 
1st Hungarian-Norwegian Summer School on Bioactive Substance Research, University of 
Tromsø, Tromsø, Norway, 15 July 2017.  
 
3. Kiss, A.; Schneider, Gy. 
A 16-hidroximetil-13-epi-ösztradiol-3-éterek sztereoszelektív átalakítása  
Innováció a Természettudományban-Doktorandusz Konferencia, Szeged, Hungary, 26 
September 2015.  
 
4. Kiss, A.; Huber J.; Zupkó, I.; Wölfling, J.; Schneider, Gy.  
Synthesis of novel hybrid molecules of estrone  
Innováció a Természettudományban-Doktorandusz Konferencia, Szeged, Hungary, 23 May 
2014.  
 
Posters: 
1. Kiss, A.; Wölfling, J.; Schneider, Gy.  
The preparation of the four stereoisomers of 16-hydroxymethyl-13-epi-estra-1,3,5(10)-trien-17-
ol-3-methyl-, and 3-benzylethers  
Xth Joint Meeting in Medicinal Chemistry, Dubrovnik, Croatia, 2528 June 2017.   
 
2. Kiss, A.; Benke, Zs.; Zupkó, I.; Wölfling, J.; Schneider, Gy. 
Sztereoizomer hibrid molekulák előállítása az ösztron sorban 
MKE Vegyészkonferencia, Hajdúszoboszló, Hungary, 1921 June 2017.  
 
3. Kiss, A.; Zupkó, I.; Wölfling, J.; Schneider, Gy.  
Ösztránvázas hibrid molekulák előállítása 
MKE 2. Nemzetközi Konferencia, Hajdúszoboszló, Hungary, 31 August2 September 2015.  
 
4. Kiss, A.; Huber, J.; Zupkó, I.; Wölfling, J.; Schneider, Gy.  
Investigation of novel hybrid molecules of estrone 
16th Tetrahedron Symposium, Berlin, Germany, 1619 June, 2015.  
 
5. Kiss, A.; Zupkó, I.; Wölfling, J.; Schneider, Gy. 
New 16-substituted estrone hybrids 
 IXth Joint Meeting in Medicinal Chemistry, Athens, Greece, 710 June 2015.  
  
13 
 
6.  Scientific publications not forming the basis of the thesis 
 
1. Fröhlich, T.; Kiss, A.; Wölfling, J.; Mernyák, E.; Kulmány, Á.; Minorics, R.; Zupkó, I.; 
Leidenberger, M.; Friedrich, O.; Kappes, B.; Hahn, F.; Marschall, M.; Schneider, Gy.; 
Tsogoeva, S. 
Synthesis of first artemisinin-estrogen hybrids and study of their activities against human 
cytomegalovirus, P. falciparum, breast and cervical cancer 
ACS Med. Chem. Lett. 2018, accepted manuscript 
IF: 3.794 
 
2. Gyovai, A.; Minorics, R.; Kiss, A.; Mernyák, E.; Schneider, Gy.; Szekeres, A.; Kerekes, E.; 
Ocsovszki, I.; Zupkó, I. 
Antiproliferative properties of newly synthesized 19-nortestosterone analogs without substantial 
androgenic activity  
Front. Pharmacol. 2018, doi: 10.3389/fphar.2018.00825. 
           IF: 3.831 
 
3. Sinka, I.; Kiss, A.; Mernyák, E.; Wölfling, J.; Schneider, Gy.; Ocsovszki, I.; Kuo, C. Y.; Wang, 
H. C.; Zupkó, I. 
Antriproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol 
analogs agains breast cancer cell lines  
Eur. J. Pharm. Sciences 2018, 123, 362370. 
IF: 3.466 
 
4. Schneider, Gy.; Kiss, A.; Mernyák, E.; Benke, Zs.; Wölfling, J.; Frank, É.; Bózsity, N.; Gyovai, 
A.; Minorics, R.; Zupkó, I.  
Stereocontrolled synthesis of the four 16-hydroxymethyl-19-nortestosterone isomers and their 
antiproliferative activites 
Steroids 2016, 105, 113120. 
IF: 2.523 
 
5. Iványi, Z.; Görbe, T.; Szabó, N.; Kiss, A.; Wölfling, J.; Schneider, Gy. 
17-Priazolil és -pirazolinil-szteroidok szintézise  
Magy. Kém. Foly. 2014, 120, 23, 116122. 
IF: - 
 
            Total IF: 13.614 
  
14 
 
7.  Scientific lectures and posters not forming the basis of the thesis 
 
Lectures: 
1. Kiss, A.; Schneider, Gy.; Wölfling, J.  
Ösztron hibrid származékok szintézise 
Tudományos Diákköri Konferencia, helyi forduló, Szeged, Hungary, 29 April 2014.  
 
2. Kiss, A.; Schneider, G.; Wölfling, J. 
Új típusú szteroid hibrid származékok szintézise 
Szegedi Ifjú Szerves Kémikusok Támogatásáért Alapítvány és a SZAB Szerves- és 
Gyógyszerkémiai Munkabizottságának 13. tudományos előadóülése, Szeged, Hungary, 7 May 
2014.  
 
3. Kiss, A.; Kovács, I.; Schneider, Gy.; Zupkó, I.; Wölfling, J. 
Synthesis of steroid-carboxylic acid conjugates  
“Research Cooperation of the University of Szeged and the University of Novi Sad in 
Development of Anticancer Drug Compounds” (RECODAC), Szeged, Hungary, 20 September 
2013.  
 
4. Kiss, A.; Kovács, I. J.; Schneider, G.; Zupkó, I.; Wölfling, J. 
Ösztránvázas karbonsav-konjugátumok szintézise  
XXXVI. Kémiai Előadói Napok, Szeged, Hungary, 2830 October 2013.  
 
5. Kiss, A.; Gábor, E.; Mahó, S. 
A dihidrotesztoszteron előállítása 
Richter Gedeon Plc., Budapest, Hungary, 29 October 2013. 
 
Posters: 
1. Sinka, I.; Mernyák, E.; Kiss, A.; Schneider, Gy.; Wölfling, J.; Ocsovszki, I.; Kuo, C. Y.; Wang, 
H. C.; Zupkó, I. 
Investigation on antiproliferative and antimetastatic properties of estrange analogs modified D-
ring against breast cancer cell lines 
3rd International Cancer Symposium, Lyon, France, 2527 September 2017. 
 
2. Sinka, I.; Mernyák, E.; Kiss, A.; Schneider, Gy.; Wölfling, J.; Ocsovszki, I.; Kuo, C. Y.; Wang, 
H. C.; Zupkó, I. 
Investigation of anticancer properties of D-ring modified estrane analogs against a panel of 
breast cancer cell lines 
7th BBBB Conference on Pharmaceutical Sciences, Balatonfüred, Hungary, 57 October 2017. 
 
3. Gyovai, A.; Minorics, R.; Bózsity, N.; Schneider, Gy.; Ocsovszki, I.; Kiss, A.; Zupkó I. 
19-Nortesztoszteron származékok antriproliferatív hatása humán malignus ráksejtvonalakon 
FAMÉ 2016: Magyar Farmakológiai, Anatómus, Mikrocirkulációs és Élettani Társaságok 
Közös Tudományos Konferenciája, Pécs, Hungary, 14 June 2016. 
 
 
 
15 
 
4. Gyovai, A.; Minorics, R.; Bózsity, N.; Kiss, A.; Ocsovszki, I.; Schneider, Gy.; Zupkó, I. 
Antiproliferative effect of 19-nortestosterone analogues on gynecological cancer cell lines 
International Conference on Bioscience 2016, Novi Sad, Serbia, 1921 September 2016. 
 
